Biotechnology Investment Today Company Profile

02:53 EST 16th December 2018 | BioPortfolio

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all aspects of the biotechnology industry. To this end, the company has developed a highly respected product portfolio, comprising its magazine, which reaches over 80,000 readers annually, its series of BioBusiness seminars and its website.

The B.I.T. magazine reaches a global audience of senior decision-makers and provides them with thought-provoking, timely and qualitative insights to critical industry issues. The content originates from industry leaders, government policy makers, market makers and analysts. It is our mission to serve the growing need for constantly updated information by Biotech CEOs and those in equivalent positions, institutional investors and venture capitalists eager to identify new and exciting business opportunities.

The renowned and highly acclaimed BioBusiness Seminar Series ensure that B.I.T. continue to maintain and further develop close relationships with the principal stakeholders in the industry. The seminars enable investors to immerse themselves in an environment which encourages, and is conducive to senior management meetings. The relaxed format allows questions to be openly asked and the conclusions drawn on company potential facilitate real business development.

Our website enables users to locate information regarding new scientific and financial developments quickly and easily providing them with an invaluable aid in identifying new investment opportunities. Our mission is to help companies by


60 Wharf Road
N1 7SF
United Kingdom


Phone: 44 (0)20 7253 5440
Fax: 44 (0)20 7253 9543

News Articles [894 Associated News Articles listed on BioPortfolio]

OncoSec Medical Incorporated (ONCS) Announces $15 Million At Market Investment from Alpha Holdings, Inc.

OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc. OncoSec Medical Incorporated (OncoSec) (ONCS), a company developing intratumoral cancer immunotherapies, today announced th...

Pfizer’s Investment Strategy

Pfizer recognises the importance of biotechnology and the need for good science. Barbara Dalton and Daniel Grant explain their different roles in Pfizer and the ways in which the company can invest to...

Clal Biotechnology Industries (CBI) - Portfolio progress continues

Edison Investment Research - Pharmaceutical & healthcare - Clal Biotechnology Industries: Clal Biotechnology Industries’ (CBI) portfolio of investments continues to demonstrate forward-looking b...

TWi Biotechnology, Inc. Announced the initiation of Phase 2 Proof-of-Concept Clinical Trial of ...

TAIPEI, Taiwan, Oct. 20, 2018 /PRNewswire/ -- TWi Biotechnology, Inc. (6610 TTO), a clinical stage biotechnology company focused on developing novel inhibitors of inflammasomes, today Read more...

CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today

Today's Daily Dose brings you news about Royalty Pharma's investment in Biohaven Pharma; Champions Oncology's partnership with NSABP Foundation and Puma Biotechnology; upcoming regulatory catalyst of ...

Biotechnology regulation update

There are two upcoming opportunities to learn about the US regulatory system for biotechnology, one on gene edited animals. Register today! The post Biotechnology regulation update appeared first on B...

Visa Invests in Behalf to Support Small Business Financing

Behalf to allow SMBs to pay its merchant partners with Visa virtual cards Investment is part of Visa's $100M FinTech investment program Visa (NYSE: V) today announced an investment and partnership...

Pfizer unveils $600m investment in venture capital arm

Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.

Drugs and Medications [43 Associated Drugs and Medications listed on BioPortfolio]

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint 2x

Act restoring anticavity fluoride cool splash spearmint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint

Act restoring anticavity fluoride mouthwash cool splash spearmint 2x [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint 2X

Act restoring anticavity fluoride cool splash vanilla mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Vanilla Mint

PubMed Articles [630 Associated PubMed Articles listed on BioPortfolio]

A network for early childhood development.

Political action and investment are critical to meet the development needs of vulnerable young children today. Early childhood development (ECD) has become a global priority: an ECD target and other E...

Investment preference promotes cooperation in spatial public goods game.

It is usually assumed that each cooperator contributes equally to different public pools in spatial public goods game. However, it is more reasonable to invest differently according to individual inve...

Can lifecycle management safeguard innovation in the pharmaceutical industry?

The pharmaceutical industry invests enormous amounts of resources (>€1 billion and >10years) in the development of new products. External factors such as intensifying foreign competition and greater...

Opportunities in biotechnology.

Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and t...

Return on Investment: Building the Case for a Nurse Manager Certificate Program.

Nursing professional development practitioners are frequently asked about program return on investment. A pre-postprogram self-assessment was developed for a Nurse Manager Certificate Program using th...

Clinical Trials [426 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

TODAY! A Mobile App Study

The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and m...

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical tr...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Companies [2591 Associated Companies listed on BioPortfolio]

Biotechnology Investment Today

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all ...

European partnering & Invest Conference

EPIC is a biotechnology conference which showcases over 60 UK and European biotechnology companies. It is the perfect opportunity to hear from and meet a range of growing biotechnology companies who n...


Mulligan Biocapital AG is an investment firm dedicated to the life sciences with a specific focus on biotechlology with healt care applications.We invest in North Amercn and european biotechnology ven...

venBio Select Advisor LLC

venBio Select Advisor LLC (“venBio Select”) is the SEC registered investment manager for venBio’s public markets strategy and its main equity investment vehicle â...

China Development Financial Holding Corporation

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s...

More Information about "Biotechnology Investment Today" on BioPortfolio

We have published hundreds of Biotechnology Investment Today news stories on BioPortfolio along with dozens of Biotechnology Investment Today Clinical Trials and PubMed Articles about Biotechnology Investment Today for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnology Investment Today Companies in our database. You can also find out about relevant Biotechnology Investment Today Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record